Numerous reports using depression-like behaviors or different animal models manipulating the expression of BDNF or its receptor TrkB suggest that BDNF/TrkB participates in the pathophysiology of depression as well as the mechanism of action of antidepressant treatments [114, 116]. Here, NTRK2 is linked to depressive symptom measurement.